These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1962773)

  • 1. Optimizing the care of lung cancer patients: a multidisciplinary approach.
    Gradishar WJ; Bitran JD
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1023-5. PubMed ID: 1962773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First advances in decades in lung cancer care.
    Johns Hopkins Med Lett Health After 50; 2005 Oct; 17(8):4-5. PubMed ID: 16247864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention, diagnosis, therapy, and follow-up of lung cancer].
    Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H;
    Pneumologie; 2010 Mar; 64 Suppl 2():e1-164. PubMed ID: 20217630
    [No Abstract]   [Full Text] [Related]  

  • 4. Updates in non-small cell lung cancer.
    Walker S
    Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and combined modality therapy for lung cancer.
    Ettinger DS
    Md Med J; 1990 Apr; 39(4):315-6. PubMed ID: 2159100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bronchial cancer--development, diagnosis, therapy, prognosis].
    Zöchbauer S; Krajnik G; Huber H
    Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer management concerns in New Zealand.
    Garrett J
    N Z Med J; 2004 Jun; 117(1196):U929. PubMed ID: 15280933
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-small cell lung cancer: new hope for a chronic illness.
    Tyson LB
    Oncol Nurs Forum; 2007 Sep; 34(5):963-70. PubMed ID: 17878125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer].
    André F; Jacot W; Pujol JL; Grunenwald D; Le Chevalier T
    Bull Cancer; 1999 Oct; Suppl 3():17-41. PubMed ID: 10585572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should inoperable pulmonary cancer be treated?].
    Klastersky J
    Rev Med Brux; 1993 Apr; 14(4):102-9. PubMed ID: 7684850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-small-cell bronchial cancer: medical approach].
    Delaunois L; Weynants P
    Rev Med Suisse Romande; 1996 Feb; 116(2):79-80. PubMed ID: 8701202
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current problems of multimodal treatment in non-small cell cancer of the lung].
    Chernichenko AV; Kiseleva ES
    Sov Med; 1990; (6):46-53. PubMed ID: 2168581
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of inoperable patients with non-small-cell lung cancer.
    Feld R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():19-24. PubMed ID: 7602831
    [No Abstract]   [Full Text] [Related]  

  • 18. Non small cell lung cancer (NSCLC): current status and future prospects.
    Pathak AK; Bhutani M; Mohan A; Guleria R; Bal S; Kochupillai V
    Indian J Chest Dis Allied Sci; 2004; 46(3):191-203. PubMed ID: 15553208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of non-small-cell lung cancer with oligometastases.
    Downey RJ; Ng KK
    Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic strategies in non-small-cell lung carcinoma: how to optimize patient management?].
    Fournel P
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S23-30. PubMed ID: 16273007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.